MEMPHIS–The Chimerix pharmaceutical company said it will give 7-year-old Josh Hardy a drug that could help him survive as part of a pilot trial.
WREG reported the company will send the drug within the next 48 hours.
In a statement posted on WREG’s website, St. Jude said, “This drug is experimental and has not yet been approved by the FDA and the safety and effectiveness of the medication has not yet been established for use in children. For this reason, it will be administered under a new treatment protocol as approved by a committee charged with compliance to federal and institutional regulations for clinical research (IRB). It is also important to understand that this remains a critical and complex medical situation.”
Josh is a patient in the intensive care unit at St. Jude.
A virus is destroying his heart and kidney.
Originally, the drug company refused to give the drug to Josh saying helping him would hurt others.